Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

• Status: Completed
• Trial end date: 2007-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effects of enoxaparin on bleeding and venous blood clots in patients with hip fracture surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanofi
• Treatments: Enoxaparin

Criteria

Inclusion Criteria:

• femoral neck inside or outside fracture

Exclusion Criteria:

• any major surgery on lower limbs within 3 months

• clinical signs of deep vein thrombosis

• use of non-steroidal anti-inflammatory drugs

• severe hepatic disease or renal insufficiency